GlassScriptPhysician profile
Muhammad Naser Imran
NPI 1922289651
$4,258.97
in general payments reported to CMS, 2019-2025
12 companies · $18.41 in 2025
The $18.41 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.91 · 2020: $51.50 · 2021: $49.23 · 2022: $2,176 · 2023: $181 · 2024: $1,740 · 2025: $18.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $970 · Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $970.11 |
| Food and Beverage | $968.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,155.67 | 2020-2024 | Amplatzer Amulet, Assurity, Tacticath |
| Medtronic, INC. | $1,799.93 | 2022-2025 | Arctic Front Advance, Pulseselect, Selectsecure |
| Actelion Pharmaceuticals US, INC. | $100.14 | 2022 | |
| Impulse Dynamics (USA) INC. | $61.08 | 2023 | Optimizer |
| Vifor Pharma, INC. | $27.30 | 2022 | |
| Pfizer INC. | $25.12 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $18.64 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.29 | 2023 | Camzyos |
| Terumo Medical Corporation | $14.54 | 2021 | |
| Chiesi USA, INC. | $14.45 | 2020 | |
| Lantheus Medical Imaging, INC. | $13.96 | 2021 | |
| Amgen INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Imran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.